Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gaetano Serviddio
DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk During Anti-HCV Treatment
PLoS ONE
Multidisciplinary
Related publications
HCV and Diabetes: Towards a ‘Sustained’ Glycaemic Improvement After Treatment With DAAs?
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
HCV and Diabetes: Towards a ‘Sustained’ Glycaemic Improvement After Treatment With DAAs? – Authors' Reply
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Rationale for Targeting VEGF, FGF, and PDGF for the Treatment of NSCLC
OncoTargets and Therapy
Oncology
Pharmacology
Response Prediction for Chronic HCV Genotype 4 Patients to DAAs
International Journal of Advanced Computer Science and Applications
Computer Science
The “Real-World” Efficacy and Safety of DAAs for the Treatment of HCV Patients Throughout Japan
Journal of Gastroenterology
Gastroenterology
Anti-Vegf Treatment Reduces Blood Supply and Increases Tumor Cell Invasion in Glioblastoma
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Rapidly Changing Seasonal Sea Levels Increase Flood Risk
Eos
Earth
Planetary Sciences
Estimation of Serum Leptin Level in Egyptian Patients With Chronic HCV After Antiviral Treatment
Journal of Gastroenterology and Hepatology Research
Hepatology
Gastroenterology
Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy
Clinical Pharmacokinetics
Pharmacology